医学
去神经支配
随机对照试验
导管
超声波
气球
临床试验
外科
内科学
心脏病学
放射科
作者
Yu Sato,Rika Kawakami,Atsushi Sakamoto,Anne Cornelissen,Masayuki Mori,Kenji Kawai,Liang Guo,Maria Romero,Frank D. Kolodgie,Renu Virmani,Aloke V. Finn
出处
期刊:Future Cardiology
[Future Medicine]
日期:2021-09-01
卷期号:17 (6): 931-944
被引量:1
标识
DOI:10.2217/fca-2020-0228
摘要
Catheter-based renal denervation is a novel treatment approach for patients with hypertension and initial unblinded trials have shown promising results. The Paradise™ Ultrasound Renal Denervation System (ReCor Medical, CA, USA) is an ultrasound-based catheter with a distal balloon that acts as a coolant to protect the renal arterial wall. This device received CE-mark in 2012. Randomized, sham-controlled trials and postmarket studies have shown promising efficacy and safety results. Currently, three additional ongoing randomized, sham-controlled trials are underway in the USA, Europe, Japan and Korea, and the results will be pivotal in device approval in some of these countries. These studies with larger numbers of patients and longer duration of follow-up are needed to further confirm the safety and efficacy of this device.
科研通智能强力驱动
Strongly Powered by AbleSci AI